ARKO Petroleum And 2 Other Value Stocks Priced Below Estimated Worth
JUMIA JMIA | 0.00 |
The United States market has shown robust performance, climbing 1.5% in the last week and an impressive 26% over the past year, with earnings projected to grow by 17% annually. In this thriving environment, identifying undervalued stocks like ARKO Petroleum and others can offer potential opportunities for investors seeking value amidst rising market trends.
Top 10 Undervalued Stocks Based On Cash Flows In The United States
| Name | Current Price | Fair Value (Est) | Discount (Est) |
| Tuniu (TOUR) | $5.94 | $11.44 | 48.1% |
| Travere Therapeutics (TVTX) | $42.84 | $84.03 | 49% |
| Rayonier (RYN) | $20.34 | $39.91 | 49% |
| Ramaco Resources (METC) | $16.51 | $32.27 | 48.8% |
| Kaspi.kz (KSPI) | $86.38 | $171.76 | 49.7% |
| iRhythm Holdings (IRTC) | $118.31 | $234.30 | 49.5% |
| FinWise Bancorp (FINW) | $12.98 | $25.54 | 49.2% |
| FB Financial (FBK) | $52.04 | $101.61 | 48.8% |
| CVR Energy (CVI) | $34.39 | $67.81 | 49.3% |
| Bitgo Holdings (BTGO) | $11.89 | $23.26 | 48.9% |
Let's dive into some prime choices out of the screener.
ARKO Petroleum (APC)
Overview: ARKO Petroleum Corp. operates as a fuel distributor in North America with a market cap of $955.69 million.
Operations: The company's revenue segments include fuel distribution as its primary business operation in North America.
Estimated Discount To Fair Value: 30.4%
ARKO Petroleum is trading at US$21.55, significantly undervalued compared to its estimated future cash flow value of US$30.95. Despite revenue growth forecasted at 4.4% annually—slower than the market average—earnings are expected to grow significantly by 23.6% per year, outpacing the broader U.S. market's growth rate of 16.7%. Recent earnings showed improved net income and EPS, indicating potential for robust cash flow generation despite challenges in covering interest payments with earnings alone.
MannKind (MNKD)
Overview: MannKind Corporation is a biopharmaceutical company that specializes in developing solutions for chronic disease care, with a market cap of approximately $1.04 billion.
Operations: The company's revenue is primarily derived from its pharmaceuticals segment, totaling $360.78 million.
Estimated Discount To Fair Value: 30.5%
MannKind, trading at US$3.28, is undervalued with an estimated future cash flow value of US$4.72. Despite recent volatility and a net loss of US$16.62 million in Q1 2026, its forecasted annual earnings growth rate exceeds market averages as it aims for profitability within three years. Revenue growth is slower at 11.8% annually but remains above the U.S. market average, supporting MannKind's potential for long-term cash flow improvement amidst industry challenges.
Jumia Technologies (JMIA)
Overview: Jumia Technologies AG operates an e-commerce platform across various regions including Africa, Europe, and the United Arab Emirates, with a market cap of approximately $930.13 million.
Operations: The company's revenue segments include an e-commerce platform operating in West, North, East, and South Africa, Europe, the United Arab Emirates, and other international markets.
Estimated Discount To Fair Value: 26%
Jumia Technologies, trading at US$7.98, is undervalued with an estimated future cash flow value of US$10.79, indicating a 26% discount. Despite reporting a Q1 2026 net loss of US$17.73 million, its earnings have grown significantly over the past five years and are forecasted to grow by a very large margin annually. With revenue projected to increase by 14.8% per year—outpacing the U.S. market average—Jumia aims for profitability within three years amidst ongoing challenges.
Next Steps
- Get an in-depth perspective on all 144 Undervalued US Stocks Based On Cash Flows by using our screener here.
- Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports.
- Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide.
Curious About Other Options?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
